Literature DB >> 3954758

Structural analysis of the asparagine-linked oligosaccharides of human complement component C3.

S Hirani, J D Lambris, H J Müller-Eberhard.   

Abstract

The asparagine-linked oligosaccharides of human C3 were characterized. The C3 oligosaccharides were released by endo-beta-N-acetylglucosaminidase H and were analysed by lectin affinity chromatography and h.p.l.c. The released oligosaccharides bound tightly to concanavalin A-Sepharose and were not retained by agarose-bound wheat-germ agglutinin, indicating that they were only of high-mannose type. Two major oligosaccharide structures were separated from both the alpha- and beta-chains of C3 by h.p.l.c. on Micropak AX-5, calibrated with high-mannose-type oligosaccharides of known structures. The oligosaccharide structures on the alpha-chain have the compositions (Man)9(GlcNAc)2-Asn and (Man)8 (GlcNAc)2-Asn, and those on the beta-chain have the compositions (Man)6(GlcNAc)2-Asn and (Man)5(GlcNAc)2-Asn.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954758      PMCID: PMC1153071          DOI: 10.1042/bj2330613

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  CONGLUTINATION: SPECIFIC INHIBITION BY CARBOHYDRATES.

Authors:  M A LEON; R YOKOHARI
Journal:  Science       Date:  1964-03-20       Impact factor: 47.728

2.  Limited degradation of the third component (C3) of human complement by human leukocyte elastase (HLE): partial characterization of C3 fragments.

Authors:  J C Taylor; I P Crawford; T E Hugli
Journal:  Biochemistry       Date:  1977-07-26       Impact factor: 3.162

Review 3.  Conglutinin and immunoconglutinins.

Authors:  P J Lachmann
Journal:  Adv Immunol       Date:  1967       Impact factor: 3.543

4.  The structural basis of the different affinities of two types of acidic N-glycosidic glycopeptides for concanavalin A--sepharose.

Authors:  T Krusius; J Finne; H Rauvala
Journal:  FEBS Lett       Date:  1976-11-15       Impact factor: 4.124

5.  Structure of the high mannose oligosaccharides of a human IgM myeloma protein. I. The major oligosaccharides of the two high mannose glycopeptides.

Authors:  A Chapman; R Kornfeld
Journal:  J Biol Chem       Date:  1979-02-10       Impact factor: 5.157

6.  Fractionation of glycopeptides by affinity column chromatography on concanavalin A-sepharose.

Authors:  S Ogata; T Muramatsu; A Kobata
Journal:  J Biochem       Date:  1975-10       Impact factor: 3.387

7.  Third component of human complement: purification from plasma and physicochemical characterization.

Authors:  B D Tack; J W Prahl
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

8.  Structural studies of the major high mannose oligosaccharide units from Chinese hamster ovary cell glycoproteins.

Authors:  E Li; S Kornfeld
Journal:  J Biol Chem       Date:  1979-03-10       Impact factor: 5.157

9.  Structures of the asparagine-linked sugar chains of human chorionic gonadotropin.

Authors:  Y Endo; K Yamashita; Y Tachibana; S Tojo; A Kobata
Journal:  J Biochem       Date:  1979-03       Impact factor: 3.387

10.  Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.

Authors:  J D Lambris; N J Dobson; G D Ross
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Authors:  Daniel Ricklin; Edimara S Reis; Dimitrios C Mastellos; Piet Gros; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

2.  A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins.

Authors:  Qiuting Hong; L Renee Ruhaak; Carol Stroble; Evan Parker; Jincui Huang; Emanual Maverakis; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2015-11-09       Impact factor: 4.466

3.  Interactions between human complement components factor H, factor I and C3b.

Authors:  C J Soames; R B Sim
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.

Authors:  B Nilsson; K Nilsson Ekdahl; D Avila; U R Nilsson; J D Lambris
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

5.  Structural Implications for the Formation and Function of the Complement Effector Protein iC3b.

Authors:  Malvina Papanastasiou; Sophia Koutsogiannaki; Yiannis Sarigiannis; Brian V Geisbrecht; Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2017-03-03       Impact factor: 5.422

6.  Dynamic structural changes during complement C3 activation analyzed by hydrogen/deuterium exchange mass spectrometry.

Authors:  Michael C Schuster; Daniel Ricklin; Krisztián Papp; Kathleen S Molnar; Stephen J Coales; Yoshitomo Hamuro; Georgia Sfyroera; Hui Chen; Michael S Winters; John D Lambris
Journal:  Mol Immunol       Date:  2008-05-05       Impact factor: 4.407

7.  Collectin-43 is a serum lectin with a distinct pattern of carbohydrate recognition.

Authors:  R W Loveless; U Holmskov; T Feizi
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

8.  Carbohydrate structures of the third component of rat complement. Presence of both high-mannose and complex type oligosaccharide chains.

Authors:  K Miki; S Ogata; Y Misumi; Y Ikehara
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

9.  Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.

Authors:  S B Laursen; S Thiel; B Teisner; U Holmskov; Y Wang; R B Sim; J C Jensenius
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

10.  Bovine serum conglutinin is a lectin which binds non-reducing terminal N-acetylglucosamine, mannose and fucose residues.

Authors:  R W Loveless; T Feizi; R A Childs; T Mizuochi; M S Stoll; R G Oldroyd; P J Lachmann
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.